Group One Trading
TAK icon

Group One Trading’s Takeda Pharmaceutical TAK Stock Holding History

Group One Trading’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-100
Closed -$1.55K – 9128
2025
Q2 		$1.55K Sell
100
-100
-50% -$1.48K ﹤0.01% 7478
2025
Q1 		$2.97K Sell
200
-1,900
-90% -$26.6K ﹤0.01% 6853
2024
Q4 		$27.8K Buy
2,100
+100
+5% +$1.37K ﹤0.01% 5490
2024
Q3 		$28.4K Sell
2,000
-700
-26% -$9.93K ﹤0.01% 5028
2024
Q2 		$34.9K Buy
2,700
+400
+17% +$5.29K ﹤0.01% 4792
2024
Q1 		$31.9K Sell
2,300
-2,500
-52% -$36.4K ﹤0.01% 5069
2023
Q4 		$68.5K Sell
4,800
-15,400
-76% -$219K ﹤0.01% 4802
2023
Q3 		$312K Buy
20,200
+15,900
+370% +$246K ﹤0.01% 3397
2023
Q2 		$67.6K Sell
4,300
-100
-2% -$1.64K ﹤0.01% 4998
2023
Q1 		$72.5K Sell
4,400
-26,600
-86% -$424K ﹤0.01% 4559
2022
Q4 		$484K Sell
31,000
-22,200
-42% -$310K ﹤0.01% 3077
2022
Q3 		$690K Sell
53,200
-39,300
-42% -$546K ﹤0.01% 2914
2022
Q2 		$1.3M Sell
92,500
-5,200
-5% -$74.2K ﹤0.01% 2484
2022
Q1 		$1.4M Sell
97,700
-44,200
-31% -$649K ﹤0.01% 2755
2021
Q4 		$1.93M Buy
141,900
+60,300
+74% +$846K ﹤0.01% 2637
2021
Q3 		$1.34M Sell
81,600
-120,600
-60% -$2.02M ﹤0.01% 3089
2021
Q2 		$3.4M Sell
202,200
-344,600
-63% -$5.87M ﹤0.01% 2078
2021
Q1 		$9.98M Buy
546,800
+421,900
+338% +$7.59M 0.01% 945
2020
Q4 		$2.27M Buy
124,900
+9,100
+8% +$160K ﹤0.01% 1938
2020
Q3 		$2.07M Buy
115,800
+500
+0.4% +$9.1K 0.01% 1567
2020
Q2 		$2.07M Buy
115,300
+68,000
+144% +$1.22M 0.01% 1450
2020
Q1 		$718K Buy
47,300
+9,000
+23% +$163K 0.01% 1783
2019
Q4 		$756K Buy
38,300
+14,800
+63% +$283K 0.01% 2116
2019
Q3 		$404K Sell
23,500
-15,700
-40% -$272K ﹤0.01% 2513
2019
Q2 		$694K Buy
39,200
+28,900
+281% +$526K 0.01% 1852
2019
Q1 		$210K Buy
+10,300
New +$207K ﹤0.01% 2662

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Group One Trading's TAK Position: Q3 2025 in Review

Group One Trading sold out of Takeda Pharmaceutical (TAK) in Q3 2025, closing a stake of 147 shares — an estimated $2.18K sold.

Group One Trading first reported a position in TAK in Q1 2019 and held it in 11 quarters. The position peaked at $754K in Q2 2022. 329 funds tracked by Wall St. Rank hold TAK as of Q3 2025.

  • Group One Trading reported no remaining Takeda Pharmaceutical position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 147 Takeda Pharmaceutical shares in Q3 2025, an estimated $2.18K.
  • Group One Trading first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 11 quarters.
  • Group One Trading's Takeda Pharmaceutical position peaked at $754K in Q2 2022.
  • 329 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.